| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |